Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neuroplasticity

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Within-subject alterations in CSF and blood flow dynamics following rhythm-control intervention in atrial fibrillation: An exploratory multimodal MRI study.

NeuroImage. Clinical·2026

Same author

Reflections from Mathias Bähr, PhD, Editor-in-Chief for Molecular and Cellular Neuroscience, 2017-2026.

Molecular and cellular neurosciences·2026

Same author

Real-time phase-contrast MRI can be used to quantify cerebrovascular reserve capacity - a comparative study to neurovascular ultrasound in healthy subjects.

Neuroimage. Reports·2026

Same author

One-Stop Management Improves Outcome for Large Vessel Occlusion Stroke.

Stroke (Hoboken, N.J.)·2026

Same author

Detection and characterization of physiological network interactions in pulsatile motion of cranial blood vessels using real-time MRI.

Frontiers in network physiology·2026

Same author

Alterations in cerebrospinal fluid levels of myelin- and oligodendrocyte-related proteins in sporadic Creutzfeldt-Jakob disease.

Acta neuropathologica communications·2026

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

Future neuroprotective strategies.

Muriel B Sättler¹, Mathias Bähr

¹Neurologische Universitätsklinik, Robert-Koch-Str. 40, 37075 Göttingen, Germany. m.saettler@web.de

Experimental Neurology

|September 1, 2009

Summary

Multiple sclerosis (MS) causes progressive disability through axonal damage. New neuroprotective therapies are needed as current treatments fail in later disease stages.

Area of Science:

Neuroimmunology
Neurobiology
Clinical Neurology

Background:

Multiple sclerosis (MS) is characterized by progressive axonal damage and neurodegeneration, leading to accumulating patient impairment.
Existing therapeutic strategies for MS primarily address inflammation, with limited efficacy in chronic progressive stages.
Understanding the molecular mechanisms of neurodegeneration in MS is crucial for developing effective treatments.

Purpose of the Study:

To review current knowledge on neuroprotective therapy strategies for MS.
To identify potential therapeutic targets for reducing long-term disability in MS patients.
To highlight ongoing clinical trials for novel MS treatments.

Main Methods:

Literature review of molecular mechanisms in MS neurodegeneration.

More Related Videos

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

Related Experiment Videos

Last Updated: Jun 20, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

Analysis of current therapeutic strategies and their limitations.

Survey of ongoing clinical trials for neuroprotective agents in MS.

Main Results:

Significant progress has been made in understanding neuronal and axonal loss in MS.
Current treatments show limited effectiveness in chronic progressive MS.
Several potential neuroprotective strategies are under investigation.

Conclusions:

Neuroprotection is a critical unmet need in multiple sclerosis management.
Targeting neurodegenerative pathways offers promise for future MS therapies.
Ongoing clinical trials are evaluating novel approaches to mitigate MS-related disability.